All In Biotech

Free tool

FAERS Monitor: Depo-Medrol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011757 or its brand name (Depo-Medrol, Methylprednisolone Acetate). Reports on generic versions are filed under their own applications.

Reports

8,121

Serious

6,901

85% of reports

Hospitalization

2,646

Death reported

1,047

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain1,628
  • off label use1,337
  • drug ineffective1,334
  • rheumatoid arthritis1,294
  • fatigue1,220
  • headache1,137
  • joint swelling967
  • nausea824
  • arthralgia780
  • drug hypersensitivity772
  • rash766
  • pyrexia736
  • drug intolerance703
  • malaise678
  • hypersensitivity665

Reports by year received

View as table
YearReports
2004102
2005103
2006130
2007103
2008126
2009174
2010307
2011290
2012376
2013272
2014192
2015311
2016327
2017353
2018355
2019563
2020554
2021376
2022519
2023527
2024717
2025891
2026453

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,038 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal1,29429.828.435,833
joint swellingSignal96720.919.718,268
drug intoleranceSignal70319.017.711,923
drug hypersensitivitySignal77210.49.76,560
hypersensitivitySignal6659.38.74,949
painSignal1,6286.96.68,398
pyrexiaSignal7365.55.22,758
arthralgiaSignal7804.94.62,435
headacheSignal1,1374.74.53,408
rashSignal7664.64.32,165
fatigueSignal1,2204.13.92,918
malaiseSignal6784.03.71,558
off label useSignal1,3374.03.83,078
nauseaSignal8242.72.5912
drug ineffectiveSignal1,3342.62.51,426

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.